Biocardia reports second quarter 2020 financial results and business highlights

San carlos, calif., aug. 13, 2020 (globe newswire) -- biocardia®, inc. [nasdaq: bcda], a leader in the development of comprehensive solutions for cardiovascular regenerative therapies, today reported financial results and business highlights for the second quarter of 2020 and filed its quarterly report on form 10-q for the three and six months ended june 30, 2020 with the securities and exchange commission on august 13, 2020.
BCDA Ratings Summary
BCDA Quant Ranking